Effectiveness of Shared Decision Making(SDM)on Patients With Poor Control Type 2 Diabetes (SDM)
調査の概要
詳細な説明
Background Diabetes and hyperglycemia not only increase the risk of complications of cardiovascular disease and lead to a situation involving exposure to danger of death. Meanwhile, the patient's self-management is one of the key factors affecting the quality control of blood sugar. Thereby, Shared Decision Making (SDM) is a patient-centered medical implementation method that healthcare professionals and patients jointly participate in treatment decision-making to reach a consensus, which can stimulate the health care ability of participants to achieve treatment goals.
Purpose: This research aims to implement the SDM model based on self-efficacy theory through individualized decision-making to strengthen the behavioral motivation of diabetic patients and finally, to improve the patient's health promotion behavior and the effectiveness of blood sugar control.
Method: Study Type: Interventional Actual Enrollment:76 participants Allocation:Randomized Intervention Model:Parallel Assignment Masking:Single(Participant)
Expected results:
It is hoped that the implementation of SDM model will be used to strengthen the behavioral motivation of diabetic patients through individualized decision-making, and to confirm whether it can effectively improve the patient's health behavior and the effectiveness of disease control.
研究の種類
入学 (実際)
段階
- 適用できない
連絡先と場所
研究場所
-
-
Taiwan
-
Tainan、Taiwan、台湾、709204
- An Nan Hospition-China Medical University
-
-
参加基準
適格基準
就学可能な年齢
- 大人
- 高齢者
健康ボランティアの受け入れ
説明
Inclusion Criteria:
- Aged>20y/o
- Diagnosed by a physician as type 2 diabetes
- The Diabetes Participated in the Diabetes Shared Care Network
- Glycosylated hemoglobin (A1C)> 7.5%
- Can communicate in Chinese or Taiwanese.
Exclusion Criteria:
- People with mental or cognitive impairment who cannot communicate
- Health Literacy score lower than 6 points
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:防止
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:独身
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
介入なし:Control group:as usual care
The control group received as usual care.
|
|
|
実験的:Experimental group:The intervention of SDM
The experimental group received the intervention of SDM 3 times for 3 months,
|
The experimental group received the intervention of SDM 3times/month for 3months, then follow the health promotion behavior compliance by phone once a month.
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Diabetes self-efficacy scale
時間枠:Pre-test (baseline)
|
assesses the confidence of diabetes patients in their ability to manage their diet, blood sugar, and physical exercise
|
Pre-test (baseline)
|
|
Diabetes self-efficacy scale
時間枠:1 months after intervnetion
|
assesses the confidence of diabetes patients in their ability to manage their diet, blood sugar, and physical exercise
|
1 months after intervnetion
|
|
Diabetes self-efficacy scale
時間枠:3 months after intervnetion
|
assesses the confidence of diabetes patients in their ability to manage their diet, blood sugar, and physical exercise
|
3 months after intervnetion
|
|
Diabetes health literacy scale
時間枠:Pre-test (baseline)
|
A disease-specific scale to measure functional, communicative and critical health literacy in primary care
|
Pre-test (baseline)
|
|
Diabetes health literacy scale
時間枠:3 months after intervnetion
|
A disease-specific scale to measure functional, communicative and critical health literacy in primary care
|
3 months after intervnetion
|
|
Diabetes health promotion scale
時間枠:Pre-test (baseline)
|
A self-report study instrument that includes the health profile, and Diabetes Health Promotion Scale
|
Pre-test (baseline)
|
|
Diabetes health promotion scale
時間枠:1 months after intervnetion
|
A self-report study instrument that includes the health profile, and Diabetes Health Promotion Scale
|
1 months after intervnetion
|
|
Diabetes health promotion scale
時間枠:3 months after intervnetion
|
A self-report study instrument that includes the health profile, and Diabetes Health Promotion Scale
|
3 months after intervnetion
|
|
Hemoglobin A1C (HbA1c) Test
時間枠:3 months after intervnetion
|
An HbA1c test shows what the average amount of glucose attached to hemoglobin has been over the past three months.
|
3 months after intervnetion
|
|
Hemoglobin A1C (HbA1c) Test
時間枠:Pre-test (baseline)
|
An HbA1c test shows what the average amount of glucose attached to hemoglobin has been over the past three months
|
Pre-test (baseline)
|
協力者と研究者
スポンサー
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。